Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Heyns

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 5, 2001
Early diagnosis of prostate cancer in the Western CapeC F Heyns, A M Naudé, A J Visser, et al.
Prostate Cancer and Prostatic Diseases|November 15, 2006
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth, C Tyrrell, K Delaere, et al.
Carcinogenesis|April 21, 2010
Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer riskE A Tindall, G Severi, H N Hoang, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 5, 2001
Early diagnosis of prostate cancer in the Western CapeC F Heyns, A M Naudé, A J Visser, et al.
Prostate Cancer and Prostatic Diseases|November 15, 2006
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth, C Tyrrell, K Delaere, et al.
Carcinogenesis|April 21, 2010
Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer riskE A Tindall, G Severi, H N Hoang, et al.
Pageof 8